Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hengerda New Materials
300946
5
Aerospace Nanhu Electronic Information Technology
688552
CN Stock MarketDetailed Quotes
688202 Shanghai Medicilon Inc.
- 30.61
- +0.34+1.12%
Noon Break May 12 11:29 CST
4.12BMarket Cap-13.39P/E (TTM)
30.82High30.10Low11.84KlotVolume30.62Open30.27Pre Close36.12MTurnover0.88%Turnover RatioLossP/E (Static)134.67MShares44.8752wk High1.94P/B4.12BFloat Cap23.3052wk Low36.32Limit Up134.67MShs Float407.19Historical High24.22Limit Down2.38%Amplitude23.30Historical Low--Dividend TTM30.51Avg Price5.47KlotAsk--Div YieldTTM100Lot Size6.03KlotBid
Shanghai Medicilon Inc. News
Medici: Investor Relations Activity Record Form (2025-05-001)
Medici: Investor Relations Activity Record Form (2025-04-001)
Medici: Guangfa Securities Co., Ltd.\'s 2024 Continuous Supervision and Follow-up Report on Shanghai Medicinal Biomedical Co., Ltd.
Medici: Medici: Announcement of Resolutions of the Fourth Meeting of the Fourth Board of Supervisors
Guangfa Securities Co., Ltd.\'s 2024 Continuous Supervision and Follow-up Report on Shanghai Medici Biomedical Co., Ltd.
Medici: Announcement of Resolutions of the Fourth Meeting of the Fourth Board of Supervisors
Medici: Announcement on participating in the 2024 Science and Technology Innovation Board Innovative Pharmaceutical Industry Group Performance Briefing and holding the 2025 First Quarter Results Briefing
Medici: Verification Report of the Special Report on the Annual Storage and Use of Funds Raised by Shanghai Medici Biomedical Co., Ltd. 2014
Medici: Medici: 2024 Internal Control Evaluation Report
Medici: Opinions of Guangfa Securities Co., Ltd. on the foreign investment and related transactions of Shanghai Medicinal Biomedical Co., Ltd.
Medici: Medici: 2025 “Improve Quality, Increase Efficiency, and Focus on Return” Action Plan
Medici: Medici: Report on the performance of supervisory duties by the Audit Committee against Lixin Certified Public Accountants (Special General Partnership)
Medici: Medici: Special report by the board of directors on the self-inspection of the independence of independent directors
Medici: Medici: Announcement of the resolution of the 2nd Workers\' Congress in 2025
Medici: Audit Report of Shanghai Medici Biomedical Co., Ltd. Operating Income Deduction Status Table for 2024
Medici: Opinions of Guangfa Securities Co., Ltd. on the storage and use of funds raised by Shanghai Medicinal Biomedical Co., Ltd. in 2024
Medici: Medici: Supervisory Board\'s Inspection Opinions on Matters Related to the Company\'s 2025 Employee Stock Ownership Plan
Medici: Medici: Announcement on preparation for impairment of accrued assets and write-off of assets for 2024
Medici: Medici: Announcement of Resolutions of the Third Meeting of the Fourth Board of Directors
Medici: Medici: Announcement of Resolutions of the Third Meeting of the Fourth Board of Supervisors
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting